Last reviewed · How we verify
NCT05363189: BestDIEP
Optimizing Postoperative Recovery After Breast Reconstruction With Autologous Tissue (BestDIEP)
trial testing Venous augmentation in Breast Reconstruction in 380 participants. Currently enrolling.
31 December 2026
Quick facts
| Lead sponsor | Vastra Gotaland Region |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 380 |
| Start date | 2 May 2022 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Venous augmentation
- Traditional ERAS (enhanced recovery after surgery) protocol
- Sahlgrenska recovery protocol
- No venous augmentation
Conditions studied
- Breast Reconstruction — all drugs for Breast Reconstruction →
- Breast Cancer — all drugs for Breast Cancer →
Sponsor
Vastra Gotaland Region — full company profile →
Who can join
Adults 18 to 100, female only, with Breast Reconstruction or Breast Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Women who have their breast reconstructed with autologous tissue seem to be more satisfied with their breast. However, autologous breast reconstruction entails a bigger operation, and the usage of more health care resources, than some other methods, such as implant-based techniques. The main objectives of the present study are to investigate if pre- peri- and postoperative protocols can be safely modified, so the operation demands less resources, while maintaining a low complication rate and a high patient satisfaction.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Three-Dimensional Disassemblable Scaffolds for Breast Reconstruction.
Kiseleva V, Bagdasarian A, Vishnyakova P, Elchaninov A, et al · · 2025 · PMID 40808084 · DOI 10.3390/polym17152036
Verify or expand the search:
- PubMed search for NCT05363189
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Reconstruction
Currently open trials in the same condition.
- NCT07230535 — Evaluation of Wellbeing and Patient Reported Outcomes After Open vs Robotic Mastectomy With DIEP Reconstruction · NA · recruiting
- NCT07293052 — Comparison of Outcome Between Grisotti Flap Versus Reverse Mirror Grisotti Flap for Central Quadrant Breast Tumors · NA · active not recruiting
- NCT07331753 — The Outcomes of Fat Grafting Combined With Latissimus Dorsi Muscle Flap for Delayed Breast Reconstruction After Mastecto · NA · recruiting
- NCT07185334 — Single-Stage Prepectoral Placement of Textured Implants Using a Polyester Mesh Endoprostheses With Fluoropolymer Coating · NA · active not recruiting
- NCT06993714 — 3D-printed Biodegradable Breast Implants for Breast Restoration · Phase 2 · recruiting
Other Vastra Gotaland Region trials
Trials by the same sponsor.
- NCT07430865 — The RECOVER Study - Postpartum Recovery of Pelvic Floor Structures and the Impact of Early Rehabilitation · NA · recruiting
- NCT07472335 — Home-based Acute Care for Older Persons Initiated by the Emergency Medical and Ambulance Services - a Retrospective Obse · not yet recruiting
- NCT07246577 — The VGR GCA Cohort: Ultrasound, Biopsy and Biomarkers - Novel Methods for Diagnosis, Monitoring and Prognosis in Giant C · recruiting
- NCT07449338 — Prospective Cohort Study of Response and Tolerability of Accelerated Intermittent Theta-burst Stimulation (1W-AiTBS) · not yet recruiting
- NCT07334340 — Modified vs Standard CDED: Evaluation of a Nordic Adaptation of Nutritional Therapy in Paediatric Crohn's Disease · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05363189 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vastra Gotaland Region
- Last refreshed: 3 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05363189.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing